Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Nu Skin
NUS
$234M
| $15.5M | ﹤0.01% |
465,401
+280,015
| +151% | +$10.3M |
|
2102
iShares Core MSCI EAFE ETF
IEFA
$196B
| $15.4M | ﹤0.01% |
228,818
-45,115
| -16% | -$3.06M |
|
2103
Wabtec
WAB
$50.5B
| $15.4M | ﹤0.01% |
140,703
-8,230
| -6% | -$817K |
|
2104
Knife River
KNF
$3.77B
| $15.4M | ﹤0.01% |
+354,731
| New | +$15.1M |
|
2105
iShares Russell 1000 Growth ETF
IWF
$128B
| $15.4M | ﹤0.01% |
224,008
-110,540
| -33% | -$7.03M |
|
2106
CALL
Vanguard Dividend Appreciation ETF
VIG
$114B
| $15.4M | ﹤0.01% |
94,700
-11,300
| -11% | -$1.77M |
|
|
JWN
2107
PUT
DELISTED
Nordstrom
JWN
| $15.4M | ﹤0.01% |
751,200
+57,900
| +8% | +$974K |
|
2108
Tyler Technologies
TYL
$13.5B
| $15.4M | ﹤0.01% |
36,900
-448
| -1% | -$173K |
|
2109
AtriCure
ATRC
$2.25B
| $15.4M | ﹤0.01% |
311,187
-28,806
| -8% | -$1.33M |
|
2110
PUT
WIX.com
WIX
$3.1B
| $15.4M | ﹤0.01% |
196,300
+15,400
| +9% | +$1.27M |
|
2111
Vericel Corp
VCEL
$2.26B
| $15.4M | ﹤0.01% |
408,669
+407,637
| +39,500% | +$13.4M |
|
2112
CALL
Doximity
DOCS
$4.42B
| $15.3M | ﹤0.01% |
451,000
+70,800
| +19% | +$2.36M |
|
2113
iShares MSCI France ETF
EWQ
$332M
| $15.3M | ﹤0.01% |
395,998
+361,046
| +1,033% | +$13.9M |
|
2114
CALL
MP Materials
MP
$10.5B
| $15.2M | ﹤0.01% |
666,300
-318,900
| -32% | -$7.31M |
|
2115
NIO
NIO
$11.3B
| $15.2M | ﹤0.01% |
1,572,820
-2,603,457
| -62% | -$22M |
|
|
AKRO
2116
DELISTED
Akero Therapeutics
AKRO
| $15.2M | ﹤0.01% |
325,892
-529,816
| -62% | -$24.3M |
|
2117
PUT
PENN Entertainment
PENN
$2.52B
| $15.2M | ﹤0.01% |
633,115
-111,600
| -15% | -$2.97M |
|
2118
CALL
Baker Hughes
BKR
$64.3B
| $15.2M | ﹤0.01% |
481,100
+81,800
| +20% | +$2.38M |
|
|
IPXXU
2119
DELISTED
Inflection Point Acquisition Corp. II Unit
IPXXU
| $15.2M | ﹤0.01% |
+1,500,448
| New | +$15.2M |
|
2120
CALL
Dynatrace
DT
$14.2B
| $15.2M | ﹤0.01% |
295,000
+155,800
| +112% | +$7.3M |
|
2121
ASML
ASML
$708B
| $15.2M | ﹤0.01% |
20,941
-95,393
| -82% | -$64.9M |
|
2122
Protagonist Therapeutics
PTGX
$10B
| $15.2M | ﹤0.01% |
548,994
-615,686
| -53% | -$15.4M |
|
2123
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.12B
| $15.1M | ﹤0.01% |
541,417
+532,560
| +6,013% | +$14.7M |
|
2124
Sprinklr
CXM
$1.61B
| $15.1M | ﹤0.01% |
1,094,111
+128,136
| +13% | +$1.66M |
|
2125
PUT
AvalonBay Communities
AVB
$26.3B
| $15.1M | ﹤0.01% |
79,700
+26,600
| +50% | +$4.75M |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.